Gilead: A Top GARP Biotech Play, But Momentum Weakens (Downgrade)
Gilead(US:GILD) Seeking Alpha·2026-01-16 18:41分组1 - The healthcare sector has shown strong performance since August 2025, but the gains have slowed at the beginning of 2026 [1] - Biotech-related areas have particularly thrived, with Gilead (GILD) being highlighted as one of the winners in this sector [1]